Standard BioTools(LAB) - 2022 Q4 - Earnings Call Presentation

(1) Other revenue includes development, grant and license revenue Standard BioTools Reconciliation of GAAP to Non-GAAP Net Loss ITEMIZED RECONCILIATION BETWEEN GAAP AND NON-GAAP NET LOSS | --- | --- | --- | --- | --- | --- | --- | --- | --- | |---------------------------------------------------------------------------------------|-------|---------------------------------------------------|-------|----------------|-------|-------------------------------------------------------|-------|-----------------| | $0 ...